Physician profile
Mohsin Q Soliman
NPI 1942320767
$46,111.37
in general payments reported to CMS, 2019-2025
42 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,908 · 2020: $1,021 · 2021: $381 · 2022: $13K · 2023: $2,893 · 2024: $21K · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $5,106 · Education: $4,750 · Travel and Lodging: $2,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,755.00 |
| Food and Beverage | $5,105.94 |
| Education | $4,750.00 |
| Travel and Lodging | $2,430.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $22,201.31 | 2022-2024 | Esophyx |
| Intuitive Surgical, INC. | $8,148.25 | 2019-2025 | |
| Davol INC. | $5,167.95 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip, Arista |
| Ethicon INC. | $1,560.00 | 2022 | |
| Applied Medical Resources Corporation | $1,118.68 | 2019 | |
| Medical Device Business Services, INC. | $912.24 | 2019 | |
| Sanara Medtech INC. | $882.03 | 2022-2023 | Celleraterx |
| Tela Bio, INC. | $818.99 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon US, LLC | $645.20 | 2019-2021 | |
| Covidien LP | $612.19 | 2019-2020 | |
| Baxter Healthcare | $595.69 | 2019-2024 | Perclot |
| Merit Medical Systems INC | $515.69 | 2024-2025 | Esophyx |
| Innovation Technologies INC | $413.91 | 2020-2024 | Irrisept |
| Stryker Corporation | $388.95 | 2019-2025 | Artix Mt |
| Integra Lifesciences Corporation | $375.53 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $284.70 | 2021-2025 | Maxtack, Transorb |
| Acera Surgical, INC. | $216.92 | 2019-2024 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $150.00 | 2019 | |
| Kerecis Limited | $116.11 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Misonix INC | $113.59 | 2020-2021 | |
| Standard Bariatrics, INC. | $111.38 | 2022 | |
| Hologic Sales and Service, LLC | $94.75 | 2024-2025 | Trident Specimen Radiography System, Localizer, Magseed |
| Apollo Endosurgery US INC | $87.93 | 2019 | |
| Teleflex LLC | $76.14 | 2023-2024 | Titan Sgs Standard Gastric Stapler, Deknatel |
| Organogenesis INC. | $58.28 | 2021-2022 | |
| Innocoll Pharmaceuticals Limited | $56.61 | 2021 | |
| Phathom Pharmaceuticals, INC. | $42.67 | 2025 | Voquezna |
| Olympus America INC. | $35.60 | 2019-2023 | Oes Choledochofiberscope |
| W. L. Gore & Associates, INC. | $33.11 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Bioventus LLC | $32.40 | 2022 | |
| Daiichi Sankyo INC. | $31.03 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.27 | 2022 | |
| Becton, Dickinson and Company | $26.54 | 2022 | |
| Aroa Biosurgery Incorporated | $24.86 | 2025 | |
| Abbvie INC. | $24.23 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Vertex Pharmaceuticals Incorporated | $20.04 | 2025 | |
| Smith+Nephew, INC. | $19.50 | 2024 | Oasis |
| Boston Scientific Corporation | $15.59 | 2021 | |
| Acell, INC. | $14.46 | 2020 | |
| Allergan, INC. | $14.01 | 2019 | |
| Avanos Medical | $13.93 | 2023 | On-Q* Pump and Accessories |
| Merck Sharp & Dohme LLC | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohsin Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.